siRNA-mediated knockdown of GLIPR1 resulted in a significant decrease in the number of melanoma and glioma cells migrating across the membrane relative to non-targeting controls (Figure 3; Figure S5 in Supplementary Material). The gene discussed is GLIPR1; the disease is central nervous system cancer.